MedTrace Logo

VF Mapping in Brugada and Early Repolarization Syndromes

NCT03764592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-11-22

No results posted yet for this study

Summary

To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with BrS and Early Repolarization.

Conditions

  • Brugada Syndrome
  • Early Repolarization Syndrome

Interventions

OTHER

radiofrequency ablation

Symptomatic patients whose substrates were identified will undergo catheter ablation; asymptomatic patients will be followed without undergoing catheter ablation.

Sponsors & Collaborators

  • University of Bordeaux

    collaborator OTHER

  • Pacific Rim Electrophysiology Research Institute

    lead OTHER

Principal Investigators

  • Koonlawee Nademanee, MD · Chulalongkorn University

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-23
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03764592 on ClinicalTrials.gov